Antibody-based approaches to diagnosis and characterization of oxidative phosphorylation diseases

Mitochondrion

Volumn 1, Issue 3, 2001, Pages 237-248

  Hanson, Bonnie J ^a   Marusich, Michael F ^a   Capaldi, Roderick A ^a  

^a UNIVERSITY OF OREGON   (United States)

Author keywords

Mitochondria; Monoclonal antibody; Oxidative phosphorylation

Indexed keywords

EID: 0040374467     PISSN: 15677249     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-7249(01)00026-5     Document Type: Article

References (62)

1. Archinard P., Moradi-Ameli M., Godinot C., Gautheron D.C. Monoclonal antibodies to mitochondrial F1-ATPase and oligomycin sensitivity conferring protein (OSCP). Tools for recognition of well-conserved and essential antigenic sites. Biochem. Biophys. Res. Commun. 123:1984;254-261.
2. Baysal B.E., Ferrell R.E., Willet-Brozick J.E., et al. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science. 287:2000;848-851.
3. Belogrudov G.I., Tomich J.M., Hatefi Y. Membrane topography and near-neighbor relationships of the mitochondrial ATP synthase subunits e, f, and g. J. Biol. Chem. 271:1996;20340-20345.
4. Bentlage H.A.C.M., Janssen A.J.M., Chomynm A., et al. Multiple deficiencies of mitochondrial DNA- and nuclear-encoded subunits of respiratory NADH dehydrogenase detected with peptide- and subunit-specific antibodies in mitochondrial myopathies. Biochim. Biophys. Acta. 1234:1995;63-73.
5. Blake J.C., Taanman J.W., Morris A.M., et al. Mitochondrial depletion syndrome is expressed in amniotic fluid cells. Am. J. Pathol. 155:1999;67-70.
6. Bourgeron T., Rustin P., Chretien D., et al. Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency. Nat. Genet. 11:1995;144-149.
7. Bouzidi M.F., Schägger H., Collombet J.M., et al. Decreased expression of ubiquinol-cytochrome c reductase subunits in patients exhibiting mitochondrial myopathy with progressive exercise intolerance. Neuromuscul. Disord. 3:1993;599-604.
8. Bresolin N., Zeviani M., Bonilla E., et al. Fatal infantile cytochrome c oxidase deficiency: decrease of immunologically detectable enzyme in muscle. Neurology. 35:1985;802-812.
9. Capaldi R.A., Marusich M.F., Taanman J.W. Mammalian cytochrome-c oxidase: characterization of enzyme and immunological detection of subunits in tissue extracts and whole cells. Methods Enzymol. 260:1995;117-132.
10. Carrozzo R., Tessa A., Vasquez-Meinije M.E., et al. The T9176G mtDNA mutation severely affects ATP production and results in Leigh Syndrome. Neurology. 56:2001;687-690.
11. Coenen M.J.H., van den Heuvel L.P., Nijtmans L.G.J., et al. SURFEIT-1 gene analysis and two-dimensional blue native gel electrophoresis in cytochrome c oxidase deficiency. Biochem. Biophys. Res. Commun. 265:1999;339-344.
12. Darley-Usmar V.M., Kennaway N.G., Buist N.R., Capaldi R.A. Deficiency in ubiquinone cytochrome c reductase in a patient with mitochondrial myopathy and lactic acidosis. Proc. Natl Acad. Sci. USA. 80:1983;5103-5106.
13. Darley-Usmar V.M., Watanabe M., Uchiyama Y., et al. Mitochondrial myopathy: tissue-specific expression of a defect in ubiquino-cytochrome c reductase. Clin. Chim. Acta. 158:1986;253-261.
14. DiMauro S., Servidei S., Zeviani M., et al. Cytochrome c oxidase deficiency in Leigh syndrome. Ann. Neurol. 22:1987;498-506.
15. DiMauro S., Bonilla E., Davidson M., Hirano M., Schon E.A. Mitochondria in neuromuscular disorders. Biochem. Biophys. Acta. 1366:1998;199-210.
16. Hanson B.J., Carrozzo R., Piemonte F., Tessa A., Robinson B.H., Capaldi R.A. Cytochrome c oxidase-deficient patients have distinct subunit assembly profiles. J. Biol. Chem. 276:2001;16296-16301.
17. Hanson B.J., Schulenberg B., Patton W.F., Capaldi R.A. A novel subfractionation approach for mitochondrial proteins: a three-dimensional mitochondrial proteome map. Electrophoresis. 22:2001;950-959.
18. 0 subunits of bovine mitochondrial ATP synthase complex: purification, antibody production, and interspecies cross-immunoreactivity. Arch. Biochem. Biophys. 284:1993;90-97.
19. Kennaway N.G., Buist N.R., Darley-Usmar V.M., et al. Lactic acidosis and mitochondrial myopathy associated with deficiency of several components of complex III of the respiratory chain. Pediatr. Res. 18:1984;991-999.
20. Köhler G., Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 256:1975;495-497.
21. Leonard J.V., Schapira A.H.V. Mitochondrial respiratory chain disorders I: mitochondrial DNA defects. Lancet. 355:2000;299-304.
22. Loeffen J., Smeitink J., Triepels R., et al. The first nuclear-encoded complex I mutation in a patient with Leigh syndrome. Am. J. Hum. Genet. 63:1998;1598-1608.
23. Loeffen J., Elpeleg O., Smeitink J., et al. Mutations in the complex I NDUFS2 gene of patients with cardiomyopathy and encephalomyopathy. Ann. Neurol. 49:2001;195-201.
24. Lopez-Mediavilla C., Vigny H., Godinot C. Docking the mitochondrial inhibitor protein IF1 to a membrane receptor different from the F1-ATPase beta subunit. Eur. J. Biochem. 215:1993;487-496.
25. Marusich M.F., Robinson B.H., Taanman J.W., et al. Expression of mtDNA and nDNA encoded respiratory chain proteins in chemically and genetically-derived Rho0 human fibroblasts: a comparison of subunit proteins in normal fibroblasts treated with ethidium bromide and fibroblasts from a patient with mtDNA depletion syndrome. Biochim. Biophys. Acta. 1362:1997;145-159.
26. Moradi-Ameli M., Godinot C. Characterization of monoclonal antibodies against mitochondrial F1-ATPase. Proc. Natl Acad. Sci. USA. 80:1983;6167-6171.
27. Munnich A., Rustin P., Rotig A., et al. Clinical aspects of mitochondrion disorders. Int. Pediatr. 7:1992;28-33.
28. Niemann S., Muller U. Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nat. Genet. 26:2000;268-270.
29. Nijtmans L.G., Taanman J.W., Muijsers A.O., Speijer D., Van den Bogert C. Assembly of cytochrome-c oxidase in cultured human cells. Eur. J. Biochem. 254:1998;389-394.
30. 1 ATP synthase. Eur. J. Biochem. 240:1996;461-467.
31. Papa S., Scacco S., Sardanelli A.M., et al. Mutation in the NDUFS4 gene of complex I abolishes cAMP-dependent activation of the complex in a child with fatal neurological syndrome. FEBS Lett. 489:2001;259-262.
32. Papadopoulou L.C., Sue C.M., Davidson M.M., et al. Fatal infantile cardioencephalomyopathy with COX deficiency and mutations in SCO2, a COX assembly gene. Nat. Genet. 23:1999;333-337.
33. Parfait B., Chretien D., Rotig A., Marsac C., Munnich A., Rustin P. Compound heterozygous mutations in the flavoprotein gene of the respiratory chain complex II in a patient with Leigh syndrome. Hum. Genet. 106:2000;236-243.
34. Petruzzella V., Vergari R., Puzziferri I., et al. A nonsense mutation in the NDUFS4 gene encoding the 18 kD (AQDQ) subunit of complex I abolishes assembly and activity of the complex in a patient with Leigh-like syndrome. Hum. Mol. Genet. 10:2001;529-535.
35. Pettus E.H., Betabet R., Cottrell B., Wallace D.C., Madyastha V., Greenamyre J.T. Immunocytochemical characterization of the mitochondrially encoded ND1 subunit of complex I (NADH: ubiquinone oxidoreductase) in rat brain. J. Neurochem. 75:2000;383-392.
36. Prelle A., Fagiolari G., Checcarelli N., et al. Mitochondrial myopathy: correlation between oxidative defect and mitochondrial DNA deletions at single fiber level. Acta Neuropathol. 87:1994;371-376.
37. Procaccio V, Mousson B., Beugnot R., et al. Nuclear DNA origin of mitochondrial complex I deficiency in fatal infantile lactic acidosis evidenced by transnuclear complementation of cultured fibroblasts. J. Clin. Invest. 104:1999;83-92.
38. Rahman S., Lake B.D., Taanman J.W., et al. Cytochrome oxidase immunohistochemistry: clues for genetic mechanisms. Brain. 123:1999;591-600.
39. Saraste M. Oxidative phosphorylation at the fin de siecle. Science. 283:1999;1488-1493.
40. Schägger H., von Jagow G. Blue native electrophoresis for isolation of membrane protein complexes in enzymatically active form. Anal. Biochem. 199:1991;223-231.
41. Schägger H., Cramer W.A., von Jagow G. Analysis of molecular masses and oligomeric states of protein complexes by blue native electrophoresis and isolation of membrane protein complexes by two-dimensional native electrophoresis. Anal. Biochem. 217:1994;220-230.
42. Schon E.A. Mitochondrial genetics and disease. Trends Biochem. Sci. 11:2000;555-560.
43. Schuelke M., Smeitink J., Mariman E., et al. Mutant NDUFV1 subunit of mitochondrial complex I causes lekodystrophy and myoclonic epilepsy. Nat. Genet. 21:1999;260-261.
44. Servidei S., Lazaro R.P., Bonilla W., Barron K.D., Zeviani M., DiMauro S. Mitochondrial encephalomyopathy and partial cytochrome c oxidase deficiency. Neurology. 37:1987;58-63.
45. Sheffler I.E. Mitochondria. first ed. 1999;Wiley, New York, NY.
46. Taanman J.W., Burton M.D., Marusich M.F., Kennaway N.G., Capaldi R.A. Subunit specific monoclonal antibodies show different steady-state levels of various cytochrome-c oxidase subunits in chronic progressive external ophthalmoplegia. Biochim. Biophys. Acta. 1315:1996;199-207.
47. Tiranti V., Hoertnagel K., Carrozzo R., et al. Mutations of SURF-1 in Leigh disease associated with cytochrome c oxidase deficiency. Am. J. Hum. Genet. 63:1998;1609-1621.
48. Tiranti V., Galimberti C., Nijtmans L., Bovolenta S., Perini M.P., Zeviani M. Characterization of SURF-1 expression and Surf-1p function in normal and disease conditions. Hum. Mol. Genet. 8:1999;2533-2540.
49. Triepels R.H., van den Heuvel L.P., Loeffen J.L., et al. Leigh syndrome associated with a mutation in the NDUFS7 (PSST) nuclear encoded subunit of complex I. Ann. Neurol. 45:1999;787-790.
50. Triepels R.H., Hanson B.J., van den Heuvel L.P., et al. Human complex I defects can be resolved by monoclonal antibody analysis into distinct subunit assembly patterns. J. Biol. Chem. 276:2001;8892-8897.
51. Tritschler H.J., Bonilla E., Lombes A., et al. Differential diagnosis of fatal and benign cytochrome c oxidase-deficient myopathies of infancy: an immunohistochemical approach. Neurology. 41:1991;300-305.
52. Tyler D. The Mitochondrion in Health & Disease. 1992;VCH Publishers, New York, NY.
53. Valnot I., Osmond S., Gigarel N., et al. Mutations of the SCO1 gene in mitochondrial cytochrome c oxidase deficiency with neonatal-onset hepatic failure and encephalopathy. Am. J. Hum. Genet. 67:2000;1104-1109.
54. Valnot I., von-Kleist-Retzow J.C., Barrientos A., et al. A mutation in the human heme A: farnesyltransferase gene (COX10) causes cytochrome c oxidase deficiency. Hum. Mol. Genet. 9:2000;1245-1249.
55. van den Heuvel L., Ruitenbeek W., Smeets R., et al. Demonstration of a new pathogenic mutation in human complex I deficiency: a 5-bp duplication in the nuclear gene encoding the 18-kD (AQDQ) subunit. Am. J. Hum. Genet. 62:1998;262-268.
56. von Kleist-Restzow J.-C., Vial E., Chatrel-Groussard K., et al. Biochemical, genetic and immunoblot analyses of 17 patients with an isolated cytochrome c oxidase deficiency. Biochim. Biophys. Acta. 1455:1999;35-44.
57. Wallace D.C. Mitochondrial diseases in man and mouse. Science. 283:1999;1482-1489.
58. Yamaguchi M., Hatefi Y. Mitochondrial NADH: ubiquinone oxidoreductase (complex I): proximity of the subunits of the flavoprotein and the iron-sulfur protein subcomplexes. Biochemistry. 32:1993;1935-1939.
59. Yao J., Shoubridge E.A. Expression and functional analysis of SURF1 in Leigh syndrome patients with cytochrome c oxidase deficiency. Hum. Mol. Genet. 8:1999;2541-2549.
60. Zeviani M., Van Dyke D.H., Servidei S., et al. Myopathy and fatal cardiopathy due to cytochrome c oxidase deficiency. Arch. Neurol. 43:1986;1198-1202.
61. Zhu Z., Yao J., Johns T., et al. SURF1, encoding a factor involved in the biogenesis of cytochrome c oxidase, is mutated in Leigh syndrome. Nat. Genet. 20:1998;337-343.
62. Zimmermann P., Kadenbach B. Modified structure and kinetics of cytochrome-c oxidase in fibroblasts from patients with Leigh syndrome. Biochim. Biophys. Acta. 1180:1992;99-106.